EyePoint EYPT
NASDAQ EYPT
$0.36 +0.00 (+0.53%)
At close: Nov 9, 2026 · 4:00 PM EST

EyePoint (EYPT) Return on Sales [ROS] (2010 - 2026)

Updated

EyePoint (EYPT) recorded Return on Sales [ROS] of -19207.10% in Q2 2026, down 18040.27 percentage points from -1166.83% a year earlier and down 6674.63 percentage points from the prior quarter.

Analysis

EyePoint (EYPT) Return on Sales [ROS] (2010 - 2026) Analysis & Trends

On a TTM basis, EyePoint's Return on Sales [ROS] came in at -11365.22% as of Jun 30, 2026, down 11000.95 percentage points year-over-year; for FY2025, it was -775.98%, down 438.93 percentage points from FY2024.

  • Annual Return on Sales [ROS] has a five-year change of -667.70 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Sales [ROS] came in at -337.06% in FY2024 (-173.93 pp), -163.13% in FY2023 (+77.52 pp), -240.65% in FY2022 (-91.00 pp) and -149.64% in FY2021 (-41.36 pp).
  • The Q2 2026 figure is the lowest quarterly Return on Sales [ROS] in data going back to Q4 2018.
  • On a year-over-year basis, Return on Sales [ROS] has declined for five consecutive quarters, with an average year-over-year change of -6080.67 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 298.64 percentage points in Q4 2023, against a drop of 18040.27 percentage points in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at -12532.47% (Q1 2026), -11345.97% (Q4 2025) and -6420.81% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 52.42%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 24.35%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 36.01%
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 30.89%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 29.12%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 35.79%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 41.71%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 32.98%
10 EyePoint 31.41 Mn -881.72 Mn 507,000.00 -19,207.10%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -19,207.10%
Mar 31, 2026 -12,532.47%
Dec 31, 2025 -11,345.97%
Sep 30, 2025 -6,420.81%
Jun 30, 2025 -1,166.83%
Mar 31, 2025 -199.72%
Dec 31, 2024 -390.40%
Sep 30, 2024 -311.17%
Jun 30, 2024 -364.52%
Mar 31, 2024 -285.18%
Dec 31, 2023 -116.58%
Sep 30, 2023 -94.71%
Jun 30, 2023 -249.98%
Mar 31, 2023 -280.54%
Dec 31, 2022 -415.22%
Sep 30, 2022 -183.76%
Jun 30, 2022 -166.16%
Mar 31, 2022 -196.73%
Dec 31, 2021 -156.36%
Sep 30, 2021 -169.04%
API Access

EyePoint Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=EYPT&period=max&api_key=YOUR_API_KEY